Patent · US Active

UspA2 protein constructs and uses thereof

US10040832B2 · kind B2 · utility

1Cited by

0References

28Claims

0Family size

Assignee

GLAXOSMITHKLINE BIOLOGICALS SA · BE

Inventors

Normand Blais · Laval, CA
Cindy Castado · Rixensart, BE
Patrick Chomez · Brussels, BE
Marianne Dewerchin · Rixensart, BE

Key dates

Filing date	Feb 20, 2015
Grant date	Aug 7, 2018
Priority date	—
Expiry date	Feb 20, 2035

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compositions comprising Moraxella catarrhalis (M. catarrhalis) Ubiquitous surface protein A2 (UspA2). More particularly, the present application relates to UspA2 protein constructs and immunogenic compositions comprising the constructs, vaccines comprising such immunogenic compositions and therapeutic uses of the same. The invention further relates to compositions comprising UspA2 in combination with at least one antigen from Haemophilus influenzae, immunogenic compositions comprising the antigens, vaccines comprising such immunogenic compositions and therapeutic uses of the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.